MI-EATON
Intelligent power management company Eaton continues to expand its capabilities and resources in Europe, Middle East, and Africa (EMEA) with the recent announcements of two grants from the Czech Republic. The grants will fund participation in two innovative mobility projects, including assisting in the design and development of an electrified off-road truck and to develop and demonstrate a new power distribution unit (PDU) and DC/DC converter (200 kW) for hydrogen fuel cell powered trucks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240307921565/en/
Eaton’s power distribution unit will be utilized in two electrified vehicle projects funded by grants from the Czech Republic. (Photo: Business Wire)
“We are continuously expanding our electrified vehicle capabilities in EMEA and forming meaningful partnerships with governments and automotive manufacturers and suppliers,” said Dr. Mihai Dorobantu, director, Technology Planning and Government Affairs, Eaton’s Mobility Group. “EMEA is an important growth region for electrified vehicles, and we are proud to help pave the way to an emissions-free future.”
One of the grants from the Czech Republic is to participate in a joint program with Tatra Trucks, a leading Czech truck manufacturer for both military and commercial applications, to produce a specialized off-road electrified truck, a prototype called the Battery Electric Tatra Truck with multi-speed Transmission (BETTT). Eaton’s contribution to the endeavor will be the integration of its power distribution unit (PDU) and award winning 4-speed transmission for medium- and heavy-duty electrified vehicles (EVs).
“We’re very excited to have been chosen to participate in this important project,” Dorobantu said. “Eaton strives to be at the forefront of innovation for all types of vehicles as the mobility industry continues its transition from internal combustion-powered vehicles to those with electrified drivetrains.”
Medium- and heavy-duty vehicle requirements are fundamentally different than passenger vehicles. Because larger vehicles, such as buses and trucks, are bigger and heavier than passenger vehicles, electrified versions require large electric motors and batteries, which add cost. However, many vehicles typically operate on routes with significant braking opportunities that generate power via regenerative braking, making electrification an attractive opportunity to reduce energy and improve performance simultaneously.
The 4-speed EV transmission, a part of Eaton’s eMobility portfolio of electrified vehicle components, solves the primary issue related to single-speed drives: contradictory requirements for high efficiency at top speeds and increased torque at launch and low speeds. It also promotes a more complete brake energy regeneration that reduces total energy consumption and battery needs.
Eaton’s PDUs connect the main battery power to the rest of the vehicle, similar to how a home service panel connects the main power source to each of the branch circuits in the house. While distributing power through the vehicle, the PDU, also known as junction boxes, or fuse boxes, also provides a safety function, protecting passengers and the vehicle’s expensive power electronics from short circuits and other electrical system faults.
“Eaton’s PDU leverages our extensive automotive experience and electrical expertise to ensure complete power protection with enhanced vehicle performance and efficiency,” Dorobantu said. “The BETTT project will allow us to gain knowledge from a specific application and demonstrate the performance benefits of our components on a system level.”
Eaton’s second grant is from the Czech government program DEFACTo (Definition and Demonstration of Fuel Cell BoP and DC/DC components) for a three-year program to develop and demonstrate a new PDU and DC/DC converter (200 kW) for hydrogen fuel cell powered trucks. In addition, an internal test bench with a fuel cell system (50 kW) will be set up at the Eaton European Innovation Center (EEIC) to expand and accelerate the company’s capabilities and developments in the field of hydrogen.
“To successfully complete this project, we are establishing a hydrogen fuel cell lab at our European Innovation Center in Prague to test out different fuel cell components, including air and hydrogen control systems, as well as working to integrate a fuel cell in a simulated vehicle or building,” Dorobantu said.
Learn more about Eaton’s EV transmission and PDU.
Eaton is an intelligent power management company dedicated to protecting the environment and improving the quality of life for people everywhere. We make products for the data center, utility, industrial, commercial, machine building, residential, aerospace and mobility markets. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy sources, helping to solve the world’s most urgent power management challenges, and building a more sustainable society for people today and generations to come.
Eaton was founded in 1911 and has been listed on the New York Stock Exchange for more than a century. We reported revenues of $23.2 billion in 2023 and serve customers in more than 160 countries. For more information, visit www.eaton.com. Follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240307921565/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
